Jump Financial, LLC Global Blood Therapeutics, Inc. Transaction History

Jump Financial, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$32.4 - $68.18 $894,726 - $1.88 Million	27,615 Added 78.96%	62,589 $4.26 Million
Q2 2022 Aug 09, 2022	BUY	$22.3 - $37.39 $779,920 - $1.31 Million	34,974 New	34,974 $1.12 Million
Q1 2021 May 17, 2021	SELL	$38.94 - $50.85 $1.03 Million - $1.35 Million	-26,500 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$37.65 - $63.77 $997,725 - $1.69 Million	26,500 New	26,500 $1.15 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.